The objectives of this component are to: 1) provide data for monitoring secular trends in measures of nutritional status in the U.S. population; 2) evaluate the effect of people's habits and behaviors, such as physical activity and the use of alcohol, tobacco, and dietary supplements on nutritional status; and 3) evaluate the effect of changes in nutrition and public health policies including welfare reform legislation, food fortification policy, and child nutrition programs on the nutritional status of the U.S. population.
These data will be used to estimate deficiencies
and toxicities of specific nutrients in the population and subgroup, to provide
population reference data, and to estimate the contribution of diet,
supplements, and other factors to serum levels of nutrients. Data will be used
in research to further define nutrient requirements as well as optimal levels
for disease prevention and health promotion.
Examined participants aged 1 year and older were eligible.
Same as in NHANES 2011-2014, population folate status in the 2015-2016 survey cycle was assessed by a combination of two analytical methods: whole-blood folate was measured by microbiologic assay, while serum folate forms were measured by isotope-dilution high performance liquid chromatography coupled to tandem mass spectrometry (LC-MS/MS). RBC folate was then calculated using the data from both assays.
There were no changes to the lab method, lab equipment, or laboratory performing the analyses for this component in the NHANES 2015-2016 cycle.
Whole Blood Folate
Microbiological assays have been used for many years to estimate the concentration of folate in blood and other tissues. In the 1990s, more robust and reliable procedures were developed which use microtiter plates for higher throughput and a cryopreserved antibiotic resistant microorganism to avoid having to work under aseptic conditions. The described procedure is an adaptation of such a method, and was introduced by the National Center for Environmental Health (NCEH) to NHANES in 2007. Diluted whole blood is added to an assay medium containing Lactobacillus rhamnosus (formerly known as Lactobacillus casei) (NCIB 10463) and all of the nutrients necessary for the growth of L. rhamnosus except folate. The inoculated medium is incubated for 45 hours at 37oC. Since the growth of L. rhamnosus is proportional to the amount of total folate present in whole blood sample; the folate level can be assessed by measuring the turbidity of the inoculated medium at 590 nm in a PowerWave X340 Microplate reader (Bio-Tek Instrument). The assay was calibrated with 5-methyl-tetrahydrofolate from Merck Cie (Eprova).
Serum Total Folate
Serum total folate was calculated as the sum of individual folate forms. Five folate forms, 5-methyl-tetrahydrofolate, folic acid, 5-formyl-tetrahydrofolate, tetrahydrofolate, and 5,10-methenyl-tetrahydrofolate are measured by isotope-dilution high performance liquid chromatography coupled to tandem mass spectrometry (LC-MS/MS) (Fazili, et al. 2013). The assay is performed by combining specimen (150 µL serum) with ammonium formate buffer and an internal standard mixture. Sample extraction and clean-up is performed by automated 96-probe solid phase extraction (SPE) using 96-well phenyl SPE plates and takes ~1 h for a 96-well plate. Folate forms are separated within 6 min using isocratic mobile phase conditions and measured by LC-MS/MS. Quantitation is based on peak area ratios interpolated against a five-point aqueous linear calibration curve using 1/x2 weighting.
Refer to the Laboratory Method Files section for
detailed description on the laboratory methods used.
Folate - RBC (December 2018)
Folate Vitamers (December 2018)
Whole blood and blood serum are processed, stored, and shipped to the Division of Laboratory Sciences, National Center for Environmental Health, Centers for Disease Control and Prevention, Atlanta, GA for analysis.
Detailed instructions on specimen collection and
processing are discussed in the NHANES
Laboratory Procedures Manual (LPM). Vials are stored under appropriate
frozen (–20°C) conditions until they are shipped to National Center for
Environmental Health for testing.
The NHANES quality assurance and quality control (QA/QC) protocols meet the 1988 Clinical Laboratory Improvement Act mandates. Detailed QA/QC instructions are discussed in the NHANES LPM.
Mobile Examination Centers (MECs)
Laboratory team performance is monitored using several techniques. NCHS and contract consultants use a structured quality assurance evaluation during unscheduled visits to evaluate both the quality of the laboratory work and the quality-control procedures. Each laboratory staff member is observed for equipment operation, specimen collection and preparation; testing procedures and constructive feedback are given to each staff member. Formal retraining sessions are conducted annually to ensure that required skill levels were maintained.
NHANES uses several methods to monitor the quality of the analyses performed by the contract laboratories. In the MEC, these methods include performing blind split samples collected during “dry run” sessions. In addition, contract laboratories randomly perform repeat testing on 2% of all specimens.
NCHS developed and distributed a quality control protocol for all the contract laboratories, which outlined the use of Westgard rules (Westgard, et al. 1981) when running NHANES specimens. Progress reports containing any problems encountered during shipping or receipt of specimens, summary statistics for each control pool, QC graphs, instrument calibration, reagents, and any special considerations are submitted to NCHS quarterly. The reports are reviewed for trends or shifts in the data. The laboratories are required to explain any identified areas of concern.
All QC procedures recommended by the manufacturers
were followed. Reported results for all assays meet the Division of Laboratory
Sciences’ quality control and quality assurance performance criteria for
accuracy and precision, similar to the Westgard rules (Caudill, et al. 2008).
The data were reviewed. Incomplete data or improbable values were sent to the performing laboratory for confirmation.
One derived variable was created in this data file. The variable was created using the following formula:
LBDRFO: The RBC folate value in nmol/L RBC (LBDRFOSI) was converted to ng/mL RBC (LBDRFO) by dividing LBDRFOSI by 2.265 (rounded to 3 significant figures).
Same as in NHANES 2011-2012 and 2013-2014, red blood cell (RBC) folate in NHANES 2015-2016 was calculated from the whole blood folate concentration as measured by microbiologic assay by adjusting for RBC volume and correcting for serum total folate concentration which was calculated as the sum of individual folate forms. The amounts of individual serum folate forms were measured by liquid chromatography-tandem mass spectrometry (LC-MS/MS). For folate forms with results lower than limit of detection (LOD), an imputed value of LOD divided by the square root of 2 was used. Serum folate forms used to calculate serum total folate concentration were: 5-methyl-tetrahydrofolate, folic acid, 5-formyl-tetrahydrofolate, tetrahydrofolate, and 5,10-methenyl-tetrahydrofolate. For more detailed information regarding folate forms data in NHANES 2015-2016, please refer to the documentation accompanying the Folate Forms – Serum (FOLFMS_I) file.
Refer to the 2015-2016 Laboratory Data Overview for general information on NHANES laboratory data.
Demographic and Other Related Variables
The analysis of NHANES laboratory data must be conducted using the appropriate survey design and demographic variables. The 2015-2016 Demographics File contains demographic data, health indicators, and other related information collected during household interviews as well as the sample design variables. The recommended procedure for variance estimation requires use of stratum and PSU variables (SDMVSTRA and SDMVPSU, respectively) in the demographic data file.
The Fasting Questionnaire File includes auxiliary information such as fasting status, the time of venipuncture, and the conditions precluding venipuncture.
This laboratory data file can be linked to the other NHANES data files using the unique survey participant identifier (i.e., SEQN).
An exact lower limit of detection (LLOD) for RBC
folate cannot be calculated because the value is a composite of whole blood
folate, serum folate, and hematocrit. Therefore, there is no LLOD for the
calculated value of RBC folate. Furthermore, the LOD of this method for whole
blood folate depends on the dilution factor (i.e., LOD = 44 nmol/L whole blood
if whole blood hemolysate is only diluted 1/40; assuming a hematocrit of 40%,
this would correspond to a RBC folate concentration of 110 nmol/L RBC).
|Code or Value||Value Description||Count||Cumulative||Skip to Item|
|83.4 to 2970||Range of Values||8099||8099|
|Code or Value||Value Description||Count||Cumulative||Skip to Item|
|189 to 6730||Range of Values||8099||8099|